This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Facebook page | MurdochChildrensResearchInstitute |
| Website | https://www.mcri.edu.au/ |
| Twitter username | MCRI_for_kids |
| Wikipedia page | https://en.wikipedia.org/wiki/Murdoch_Childrens_Research_Institute |
| Instagram username | murdoch_childrens |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 25 | 925,710 | 1,526,112 | -27,443 | 253,700 | 278,947 | 506,656 | 569,491 | 925,710 | 1,324,476 | 1,499,099 | 2,994,783 | 4,771,414 | 4,992,818 |
| Global health | 25 | 925,710 | 1,526,112 | -27,443 | 253,700 | 278,947 | 506,656 | 569,491 | 925,710 | 1,324,476 | 1,499,099 | 2,994,783 | 4,771,414 | 4,992,818 |
| Donor | Total | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 38,152,788.00 | 542,371.00 | 3,623,428.00 | 5,368,934.00 | 5,387,102.00 | 12,977,601.00 | 6,072,998.00 | 1,432,366.00 | 1,499,099.00 | 1,248,889.00 |
| Total | 38,152,788.00 | 542,371.00 | 3,623,428.00 | 5,368,934.00 | 5,387,102.00 | 12,977,601.00 | 6,072,998.00 | 1,432,366.00 | 1,499,099.00 | 1,248,889.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 25) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | -27,443.00 | 25 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To support the 11th International Symposium on Pneumococci and Pneumococcal Diseases, the international pneumococcal experts meeting held Melbourne, Australia in 2018.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 569,814.00 | 15 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to overcome the many challenges of getting oxygen to seriously ill children with severe pneumonia in remote rural hospitals and health centers; Aid type: Project-type interventions. Affected countries: Nigeria|Papua new guinea. | |
| Bill and Melinda Gates Foundation | 278,947.00 | 21 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to generate robust data as part of the single-dose HPV evidence generation process; Aid type: Project-type interventions. Affected countries: Fiji. | |
| Bill and Melinda Gates Foundation | 496,438.00 | 19 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate nasopharyngeal carriage in children with pneumonia 4 years post introduction of pneumococcal conjugate vaccine vaccination to determine herd impact on unimmunized; Aid type: Project-type interventions. Affected countries: Lao people's democratic republic (the). | |
| Bill and Melinda Gates Foundation | 112,973.00 | 24 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to generate robust data as part of the single-dose HPV evidence generation process.; Aid type: Project-type interventions. Affected countries: Mongolia. | |
| Bill and Melinda Gates Foundation | 599,983.00 | 14 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide support for a project manager to provide targeted clinical and regulatory support to BioFarma’s RV3 rotavirus vaccine development program; Aid type: Project-type interventions. Affected countries: Indonesia. | |
| Bill and Melinda Gates Foundation | 1,324,476.00 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide evidence to help understand why vaccine recipients in some instances do not respond to an oral rotavirus vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 253,700.00 | 23 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | To support the 11th International Symposium on Pneumococci and Pneumococcal Diseases, the international pneumococcal experts meeting held Melbourne, Australia in 2018.; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 556,911.00 | 17 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to fund a substudy of a pneumococcal conjugate vaccine (PCV) impact, to evaluate the impact of PCV-13 introduction on the incidence of respiratory syncytial virus and/or influenza related severe pneumonia among children under age 5; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,799,668.00 | 7 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a low cost rotavirus vaccine that could be used in a developing world setting to prevent vaccine preventable deaths in infants and children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,999,775.00 | 5 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to produce immunological and microbiological evidence of the effectiveness of alternate dosing schedules of pneumococcal conjugate vaccines using fewer doses; Aid type: Project-type interventions. Affected countries: Viet nam. | |
| Bill and Melinda Gates Foundation | 569,491.00 | 16 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to overcome the many challenges of getting oxygen to seriously ill children with severe pneumonia in remote rural hospitals and health centers; Aid type: Project-type interventions. Affected countries: Nigeria|Papua new guinea. | |
| Bill and Melinda Gates Foundation | 265,696.00 | 22 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to examine a new mechanism that may influence rotavirus vaccine take, and improve our understanding of immunological correlates of protection; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,771,414.00 | 3 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to overcome the many challenges of getting oxygen to seriously ill children with severe pneumonia in remote rural hospitals and health centers; Aid type: Project-type interventions. Affected countries: Nigeria|Papua new guinea. | |
| Bill and Melinda Gates Foundation | 349,992.00 | 20 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to contribute to the understanding of whether the frequency and intensity of social contact affects pneumococcal carriage rates and density, and if so, whether pneumococcal conjugate vaccination is able to overcome the effects of social contact on the car; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,994,783.00 | 6 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to demonstrate how nasopharyngeal (NP) carriage surveillance in hospitalized children with respiratory illness or pneumonia can be used to estimate the pneumococcal conjugate vaccine coverage required to show evidence of herd immunity; Aid type: Project-type interventions. Affected countries: Australia|Lao people's democratic republic (the)|Papua new guinea|Mongolia. | |
| Bill and Melinda Gates Foundation | 4,990,000.00 | 2 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop a low cost rotavirus vaccine that could be used in a developing world setting to prevent vaccine preventable deaths in infants and children; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,992,818.00 | 1 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to produce immunological and microbiological evidence of the effectiveness of alternate dosing schedules of pneumococcal conjugate vaccines using fewer doses; Aid type: Project-type interventions. Affected countries: Viet nam. | |
| Bill and Melinda Gates Foundation | 3,096,211.00 | 4 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to monitor pneumococcal carriage and vaccine impact. Monitoring pneumococcal carriage and vaccine impact. Investment start date: 11/14/2013 to end date: 12/31/2016. Grantee name: Murdoch Childrens Research Institute; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,498,905.00 | 9 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,477,882.00 | 10 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 506,656.00 | 18 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide a pathway to select methods to detect carriage of multiple serotype of Streptococcus pneumoniae that can be used in resource-poor countries to facilitate monitoring of the impact of introducing pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 925,710.00 | 13 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to develop an effective, low cost, oral, human neonatal rotavirus vaccine aimed at prevention of rotavirus gastroenteritis from birth, for infants and children worldwide; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,499,099.00 | 8 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide a pathway to select methods to detect carriage of multiple serotype of Streptococcus pneumoniae that can be used in resource-poor countries to facilitate monitoring of the impact of introducing pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 1,248,889.00 | 12 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to provide a pathway to select methods to detect carriage of multiple serotype of Streptococcus pneumoniae that can be used in resource-poor countries to facilitate monitoring of the impact of introducing pneumococcal vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |